Chart Industries, Inc.  

(Public, NASDAQ:GTLS)   Watch this stock  
Find more results for GTLS
34.81
May 22 - Close
NASDAQ real-time data - Disclaimer
Currency in USD
Range     -
52 week 27.34 - 84.94
Open     -
Vol / Avg. 0.00/538,442.00
Mkt cap 1.06B
P/E 14.26
Div/yield     -
EPS 2.44
Shares 30.54M
Beta 2.10
Inst. own 98%
Jul 29, 2015
Q2 2015 Chart Industries Inc Earnings Release (Estimated) - 9:30AM EDT - Add to calendar
May 28, 2015
Chart Industries Inc Annual Shareholders Meeting - 9:00AM EDT - Add to calendar
Apr 30, 2015
Q1 2015 Chart Industries Inc Earnings Call
Apr 30, 2015
Q1 2015 Chart Industries Inc Earnings Release
Feb 24, 2015
Q4 2014 Chart Industries Inc Earnings Call
Feb 24, 2015
Q4 2014 Chart Industries Inc Earnings Release
More events from DailyFinance »    

Key stats and ratios

Q1 (Mar '15) 2014
Net profit margin 2.15% 6.96%
Operating margin 6.10% 11.58%
EBITD margin - 15.20%
Return on average assets 1.45% 5.68%
Return on average equity 2.39% 10.02%
Employees 5,407 -
CDP Score - -

Address

1 Infinity Corporate Centre Dr Ste 300
GARFIELD HEIGHTS, OH 44125-5370
United States - Map
+1-440-7531490 (Phone)
+1-302-6745266 (Fax)

Website links

External links

Analyst Estimates - MarketWatch
SEC Filings - EDGAR Online
Major Holders - MSN Money

Description

Chart Industries, Inc. is an independent global manufacturer of engineered equipment used in the production, storage and end-use of hydrocarbon and industrial gases. The Company supplies engineered equipment used throughout the global liquid gas supply chain. It operates in three segments: energy and chemicals (E&C), distribution and storage or (D&S), and biomedical. The E&C and D&S segments manufacture products used primarily in energy-related and general industrial applications, such as the separation, liquefaction, distribution and storage of hydrocarbon and industrial gases. Through its BioMedical segment, it supplies cryogenic and other equipment used in the storage and distribution of biological materials and oxygen, used primarily in the medical, biological research and animal breeding industries.

Officers and directors

Samuel F. Thomas Chairman of the Board, President, Chief Executive Officer
Age: 63
Bio & Compensation  - Reuters
Trading Activity - Yahoo Finance
Michael F Biehl Chief Financial Officer, Executive Vice President
Age: 59
Bio & Compensation  - Reuters
Kenneth J. Webster Vice President, Chief Accounting Officer, Controller
Age: 52
Bio & Compensation  - Reuters
Matthew J Klaben Vice President, General Counsel, Secretary
Age: 45
Bio & Compensation  - Reuters
Michael W. Press Lead Independent Director
Age: 68
Bio & Compensation  - Reuters
W. Douglas Douglas Brown Independent Director
Age: 69
Bio & Compensation  - Reuters
Richard E. Goodrich Independent Director
Age: 71
Bio & Compensation  - Reuters
Steven W. Krablin Independent Director
Age: 65
Bio & Compensation  - Reuters
Thomas L. Williams Independent Director
Age: 56
Bio & Compensation  - Reuters